Exiqon names Harvard Medical School facility as MicroRNA Screening Center of Excellence
EXQNF | Quote | Chart | News | PowerRating -- Life science and diagnostics company Exiqon A/S (NASDAQ OMX
Copenhagen:EXQ) said on Monday that the Harvard Medical School
ICCB-Longwood Screening Facility (ICCB-L) has been recognised as a
MicroRNA Screening Center of Excellence.
The company said that ICCB-L is the first institution to be inducted as
an Exiqon microRNA Center of Excellence in the area of functional
studies.
ICCB-L supports investigators at Harvard Medical School and associated
hospitals and institutions for high-throughput screening of small
molecule and RNAi libraries.
The facility will be providing the Exiqon LNA microRNA Knockdown
Library as a screening tool for a new consortium of Harvard-affiliated
investigators.
Comments on this story may be sent to admin@m2.com
For full details on (EXQNF) EXQNF. (EXQNF) has Short Term PowerRatings at TradingMarkets. Details on (EXQNF) Short Term PowerRatings is available at This Link.
- Bharat Book Bureau: Exiqon AS - Financial Analysis Review - 02/01/10
- Exiqon to Present at 28th J.P. Morgan Healthcare Conference - 12/22/09
- Exiqon A/S plans sale of CLIA laboratory operation in US - 12/17/09
- Exiqon to Divest its U.S. CLIA Laboratory Operation Oncotech, Inc. - 12/17/09
- BiomedReports: News and FDA Updates for Clarient (Nasdaq:CLRT), WuXi (NYSE:WX), Exiqon A/S (NASDAQ:OMX) - 12/01/09
- More News >>


